# DiaMedica Therapeutics Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:afe35ff8-1b93-4754-a869-e5a84d75305f | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/diamedica-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 19 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-10T04:46:20.080096+00:00 | | Last reviewed | 2026-10-10T04:46:20.080096+00:00 | ## Identity - Legal name: DiaMedica Therapeutics Inc. - Display name: DiaMedica Therapeutics Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-10T11:57:37.733651+00:00 | | Completeness | 0.409 | | Record Quality | 0.843 | | Directors | 7 | | Committees | 4 | | Governance events | 14 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Charles Semba, M.D.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:5 - Daniel O'Connor: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:6 - James Parsons: Director. Status: current. Independent: true. Since: 2015-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:7 - Michael Giuffre, M.D.: Director. Status: current. Independent: true. Since: 2010-01-01. claim_id=alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:8 - Richard Kuntz, M.D., M.Sc.: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:9 - Rick Pauls: Director. Status: current. Independent: false. Since: 2005-01-01. claim_id=alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:10 - Tom Lewis: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member); Audit; Compensation (member); Compensation (member). claim_id=alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:11 ## Committees - Audit (audit). Chair: James Parsons. Members: James Parsons (chair, current); Tom Lewis (member, current). committee_id=alpha:committee:diamedica-therapeutics-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: James Parsons (member, current). committee_id=alpha:committee:diamedica-therapeutics-inc:audit-chair - Audit; Compensation (audit). Chair: NOT_PUBLISHED. Members: Tom Lewis (member, current). committee_id=alpha:committee:diamedica-therapeutics-inc:audit-compensation - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Tom Lewis (member, current). committee_id=alpha:committee:diamedica-therapeutics-inc:compensation ## Executive leadership - Julie Krop, M.D.: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:12 - Rick Pauls: President and Chief Executive Officer, Director [CEO]. Status: current. claim_id=alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:13 - Scott Kellen: Chief Financial Officer and Secretary [CFO]. Status: current. claim_id=alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:14 ## Governance events - EXECUTIVE_APPOINTED: Julie Krop, M.D. executive of DiaMedica Therapeutics Inc., effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:13c2d5815e41t0 - CEO_CHANGED: Rick Pauls executive of DiaMedica Therapeutics Inc., effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:11jemk42zioa8 - CFO_CHANGED: Scott Kellen executive of DiaMedica Therapeutics Inc., effective 2026-03-30. Effective: 2026-03-30. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:100cuvqoyb1zs - DIRECTOR_APPOINTED: Daniel O'Connor seat on DiaMedica Therapeutics Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:1wogxv323eg9 - DIRECTOR_APPOINTED: Richard Kuntz, M.D., M.Sc. seat on DiaMedica Therapeutics Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:1okr5zgvdei4s - DIRECTOR_APPOINTED: Tom Lewis seat on DiaMedica Therapeutics Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:nsl71f1os8twh - COMMITTEE_CREATED: Audit; Compensation committee of DiaMedica Therapeutics Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:v7dn0d1ask719 - COMMITTEE_MEMBER_ADDED: Tom Lewis member of Audit; Compensation, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:1s09o674niv0z - DIRECTOR_APPOINTED: Charles Semba, M.D. seat on DiaMedica Therapeutics Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:x2fibsk7xrf2 - DIRECTOR_APPOINTED: James Parsons seat on DiaMedica Therapeutics Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:amvl3vu494of - COMMITTEE_CREATED: Audit · Chair committee of DiaMedica Therapeutics Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:124ll77anr38n - COMMITTEE_MEMBER_ADDED: James Parsons member of Audit · Chair, effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:1p632zm19f8wrs - DIRECTOR_APPOINTED: Michael Giuffre, M.D. seat on DiaMedica Therapeutics Inc., effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:1d3oho9sidhid - DIRECTOR_APPOINTED: Rick Pauls seat on DiaMedica Therapeutics Inc., effective 2005-01-01. Effective: 2005-01-01. Detected: 2026-10-10T04:46:20.080096+00:00. event_id=alpha:event:transition:h9we4y1vy5obo ## Scoped resources - `alpha://company/diamedica-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record - `alpha://company/diamedica-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=identity - `alpha://company/diamedica-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/diamedica-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=board - `alpha://company/diamedica-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=committees - `alpha://company/diamedica-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=leadership - `alpha://company/diamedica-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=ownership - `alpha://company/diamedica-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=financials - `alpha://company/diamedica-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/diamedica-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=compensation - `alpha://company/diamedica-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=governance - `alpha://company/diamedica-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/diamedica-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=audit - `alpha://company/diamedica-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=legal - `alpha://company/diamedica-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=risk - `alpha://company/diamedica-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=cyber - `alpha://company/diamedica-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/diamedica-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=agents - `alpha://company/diamedica-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/diamedica-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=events - `alpha://company/diamedica-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=relationships - `alpha://company/diamedica-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=assessments - `alpha://company/diamedica-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:committee_appointment:16: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:james-parsons","name":"James Parsons"},"source_id":"board_seats"}` - Claim alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:tanya-lewis","name":"Tom Lewis"},"source_id":"board_seats"}` - Claim alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:tanya-lewis","name":"Tom Lewis"},"source_id":"board_seats"}` ## Leadership - Charles Semba, M.D.: Director. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:5. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3. - Daniel O'Connor: Director. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:6. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3. - James Parsons: Director, Audit · Chair. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:7. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3. - Michael Giuffre, M.D.: Director. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:8. Valid from: 2010-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3. - Richard Kuntz, M.D., M.Sc.: Director. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:9. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3. - Rick Pauls: Director. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:10. Valid from: 2005-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3. - Tom Lewis: Director, Audit; Compensation. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:11. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3. - Julie Krop, M.D.: Chief Medical Officer. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:12. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cf40d0eed08203ab59df2e90f6a8b5bd7f851111d0738115456fe78a096933dc. - Rick Pauls: President and Chief Executive Officer, Director. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:13. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:e3f3e2c9a46691d1f35beb4ca3fa99ca1fbf2a6ff62409f76f628458c440cb2d. - Scott Kellen: Chief Financial Officer and Secretary. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:leadership_role:14. Valid from: 2026-03-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:0149d83920588d3e6a30014b70780cce044093d89f2ebef7e0fd17aaf836c10f. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair James Parsons; Members James Parsons (Chair); Tom Lewis. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:committee_record:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c145fd8487b8d443f6152c01501b4a1de9de3882047db12e47bf5cac8f544404. - Compensation: Chair not stated; Members Tom Lewis. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c145fd8487b8d443f6152c01501b4a1de9de3882047db12e47bf5cac8f544404. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - DiaMedica Therapeutics Inc.. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0b4c3bf38bd99c369ca288b310a707372127b7b69709ca39cdab774f0c4f73ad. ## Entity Status - Public listing published. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0b4c3bf38bd99c369ca288b310a707372127b7b69709ca39cdab774f0c4f73ad. ## Published Fact - US. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0b4c3bf38bd99c369ca288b310a707372127b7b69709ca39cdab774f0c4f73ad. ## Committee Appointment - James Parsons: chair, Audit. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:committee_appointment:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c145fd8487b8d443f6152c01501b4a1de9de3882047db12e47bf5cac8f544404. - Tom Lewis: member, Audit. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c145fd8487b8d443f6152c01501b4a1de9de3882047db12e47bf5cac8f544404. - Tom Lewis: member, Compensation. Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c145fd8487b8d443f6152c01501b4a1de9de3882047db12e47bf5cac8f544404. ## Security Listing - DMAC (NASDAQ). Claim: alpha:claim:company:afe35ff8-1b93-4754-a869-e5a84d75305f:security_listing:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:0b4c3bf38bd99c369ca288b310a707372127b7b69709ca39cdab774f0c4f73ad. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:0b4c3bf38bd99c369ca288b310a707372127b7b69709ca39cdab774f0c4f73ad: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/diamedica-therapeutics-inc). - alpha:projection-evidence:document:b94589720e18958151bf2013ea7d8352fe8b7a92a2d0ec410339a8a898b052d3: [DiaMedica Therapeutics Inc. DEF 14A 2026-04-01](https://www.sec.gov/Archives/edgar/data/1401040/000143774926010879/dmtp20260331_def14a.htm). - alpha:projection-evidence:document:cf40d0eed08203ab59df2e90f6a8b5bd7f851111d0738115456fe78a096933dc: [DMAC 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1401040/000143774926010342/dmtp20251231_10k.htm). - alpha:projection-evidence:document:e3f3e2c9a46691d1f35beb4ca3fa99ca1fbf2a6ff62409f76f628458c440cb2d: [DMAC 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1401040/000143774926010342/dmtp20251231_10k.htm). - alpha:projection-evidence:document:0149d83920588d3e6a30014b70780cce044093d89f2ebef7e0fd17aaf836c10f: [DMAC 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1401040/000143774926010342/dmtp20251231_10k.htm). - alpha:projection-evidence:c145fd8487b8d443f6152c01501b4a1de9de3882047db12e47bf5cac8f544404: [Audit](https://www.sec.gov/Archives/edgar/data/1401040/000143774926010879/dmtp20260331_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/diamedica-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/diamedica-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/diamedica-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/diamedica-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-10T11:57:37.332563+00:00; recorded 2026-10-10T11:57:37.332563+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.